KOSDAQ · Healthcare · ₩26B
₩2,015+8.92%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 2.7% · as of 26.10.28
Among 37 신약 개발 peers
Quarterly Revenue Growth
“미국 검사 사업을 키우는 힘이 실적 회복의 열쇠예요.”
In the company's words · 2026 2분기 filing